Literature DB >> 16489342

The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation.

Irina Naguibneva1, Maya Ameyar-Zazoua, Anna Polesskaya, Slimane Ait-Si-Ali, Reguina Groisman, Mouloud Souidi, Sylvain Cuvellier, Annick Harel-Bellan.   

Abstract

Deciphering the mechanisms underlying skeletal muscle-cell differentiation in mammals is an important challenge. Cell differentiation involves complex pathways regulated at both transcriptional and post-transcriptional levels. Recent observations have revealed the importance of small (20-25 base pair) non-coding RNAs (microRNAs or miRNAs) that are expressed in both lower organisms and in mammals. miRNAs modulate gene expression by affecting mRNA translation or stability. In lower organisms, miRNAs are essential for cell differentiation during development; some miRNAs are involved in maintenance of the differentiated state. Here, we show that miR-181, a microRNA that is strongly upregulated during differentiation, participates in establishing the muscle phenotype. Moreover, our results suggest that miR-181 downregulates the homeobox protein Hox-A11 (a repressor of the differentiation process), thus establishing a functional link between miR-181 and the complex process of mammalian skeletal-muscle differentiation. Therefore, miRNAs can be involved in the establishment of a differentiated phenotype - even when they are not expressed in the corresponding fully differentiated tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489342     DOI: 10.1038/ncb1373

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  233 in total

Review 1.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

2.  miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis.

Authors:  Haitao Bai; Zhongwei Cao; Chong Deng; Lili Zhou; Chun Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-01       Impact factor: 4.553

Review 3.  Epigenetic regulation of skeletal myogenesis.

Authors:  Valentina Saccone; Pier Lorenzo Puri
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

4.  MicroRNA-128 regulates the proliferation and differentiation of bovine skeletal muscle satellite cells by repressing Sp1.

Authors:  Yang Dai; Wei Ran Zhang; Yi Min Wang; Xin Feng Liu; Xin Li; Xiang Bin Ding; Hong Guo
Journal:  Mol Cell Biochem       Date:  2016-02-01       Impact factor: 3.396

Review 5.  MicroRNAs and genomic instability.

Authors:  Konrad Huppi; Natalia Volfovsky; Mark Mackiewicz; Timothy Runfola; Tamara L Jones; Scott E Martin; Robert Stephens; Natasha J Caplen
Journal:  Semin Cancer Biol       Date:  2006-10-26       Impact factor: 15.707

6.  Optimization of feline immunodeficiency virus vectors for RNA interference.

Authors:  Scott Q Harper; Patrick D Staber; Christine R Beck; Sarah K Fineberg; Colleen Stein; Dalyz Ochoa; Beverly L Davidson
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5.

Authors:  Yun Chen; David H Gorski
Journal:  Blood       Date:  2007-10-23       Impact factor: 22.113

8.  Regulation of the Caenorhabditis elegans posterior Hox gene egl-5 by microRNA and the polycomb-like gene sop-2.

Authors:  Hongjie Zhang; Scott W Emmons
Journal:  Dev Dyn       Date:  2009-03       Impact factor: 3.780

Review 9.  The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma.

Authors:  Xiaoping Luo; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

10.  miRNA and piRNA localization in the male mammalian meiotic nucleus.

Authors:  E Marcon; T Babak; G Chua; T Hughes; P B Moens
Journal:  Chromosome Res       Date:  2008-01-22       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.